rosiglitazone has been researched along with 4-hydroxy-2-nonenal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, T; Itoh, K; Leake, DS; Mann, GE; Ruiz, E; Unoki, H; Yamamoto, M | 1 |
| Barrera, G; Briatore, F; Cerbone, A; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S; Toaldo, C | 1 |
2 other study(ies) available for rosiglitazone and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal.
Topics: Adaptor Proteins, Signal Transducing; Aldehydes; Animals; Aorta; Arteriosclerosis; CD36 Antigens; DNA-Binding Proteins; Female; Gene Expression Regulation; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Homeodomain Proteins; Lipid Peroxidation; Lipoproteins, LDL; Macrophages, Peritoneal; Maleates; Membrane Proteins; Mice; Mice, Inbred ICR; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-E2-Related Factor 2; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Scavenger; Rosiglitazone; Sequestosome-1 Protein; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcription, Genetic; Up-Regulation | 2004 |
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Topics: Aldehydes; Apoptosis; bcl-2-Associated X Protein; Caco-2 Cells; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cross-Linking Reagents; Cysteine Proteinase Inhibitors; Drug Synergism; Gene Expression; Humans; Ligands; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones | 2007 |